It has been demonstrated in mice studies using combination antibiotic therapy (ABX) that gram-negative and gram-positive bacteria and Lactobacillus fermentum could affect tumor responses in mice using TLR9 ligands, thus, reducing tumor damage to DNA (Iida et al., 2013). The gene discussed is TLR9; the disease is neoplasm.